A Double-Blind, Vehicle-Controlled, Rising Dose, Safety, Tolerability, Pharmacokinetic and Preliminary Efficacy Study of INCB018424 Phosphate Cream When Applied to Patients With Plaque Psoriasis.
Phase of Trial: Phase II
Latest Information Update: 19 Jan 2018
At a glance
- Drugs Ruxolitinib (Primary) ; Betamethasone dipropionate; Calcipotriol
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Incyte Corporation
- 21 Jun 2010 Actual end date change from Jan 2009 to Apr 2009 as reported by ClinicalTrials.gov.
- 14 Oct 2009 New trial record.